Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Oct;20(4):401–404. doi: 10.1111/j.1365-2125.1985.tb05084.x

Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.

K K Pun, C K Yeung, M K Chan
PMCID: PMC1400880  PMID: 3907676

Abstract

Effects of oral administration of equipotent antihypertensive doses of propranolol and nadolol on renal function were examined in 20 hypertensive patients with moderately impaired renal function. Creatinine clearance increased, and serum beta 2-microglobulin concentrations decreased, when patients were switched from propranolol to nadolol therapy (creatinine clearance = 46.7 +/- 4.9 ml min-1 on propranolol and 52.7 +/- 5.9 on nadolol; beta 2-microglobulin = 6.14 +/- 0.66 mg l-1 on propranolol and 5.62 +/- 0.62 on nadolol). When patients were put back on propranolol, their creatinine clearances (45.9 +/- 5.0 ml min-1) and serum beta 2-microglobulin concentrations (6.51 +/- 0.67 mg l-1) returned to values comparable to those obtained before the change to nadolol was made. Serum beta 2-microglobulin concentrations correlated significantly with creatinine clearance (r = -0.819, P less than 0.001).

Full text

PDF
401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashbrook D. W., Purdy R. E., Hurlbut D. E., Rains L. A., Reidy J. P., Stratford R. E. A novel response to propranolol: contractile response in the isolated rabbit ear artery. Life Sci. 1980 Jan 14;26(2):155–163. doi: 10.1016/0024-3205(80)90060-0. [DOI] [PubMed] [Google Scholar]
  2. Bauer J. H., Brooks C. S. The long-term effect of propranolol therapy on renal function. Am J Med. 1979 Mar;66(3):405–410. doi: 10.1016/0002-9343(79)91059-3. [DOI] [PubMed] [Google Scholar]
  3. Dreslinski G. R., Messerli F. H., Dunn F. G., Suarez D. H., Reisin E., Frohlich E. D. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension. Circulation. 1982 Jun;65(7):1365–1368. doi: 10.1161/01.cir.65.7.1365. [DOI] [PubMed] [Google Scholar]
  4. Hollenberg N. K., Adams D. F., McKinstry D. N., Williams G. H., Borucki L. J., Sullivan J. M. beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation. Br J Clin Pharmacol. 1979;7 (Suppl 2):219S–225S. doi: 10.1111/j.1365-2125.1979.tb04693.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ibsen H., Sederberg-Olsen P. Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci. 1973 Feb;44(2):129–134. doi: 10.1042/cs0440129. [DOI] [PubMed] [Google Scholar]
  6. Lydtin H., Kusus T., Daniel W., Schierl W., Ackenheil M., Kempter H., Lohmöller G., Niklas M., Walter I. Propranolol therapy in essential hypertension. Am Heart J. 1972 May;83(5):589–595. doi: 10.1016/0002-8703(72)90397-3. [DOI] [PubMed] [Google Scholar]
  7. Waal-Manning H. J., Hobson C. H. Renal function in patients with essential hypertension receiving nadolol. Br Med J. 1980 Aug 9;281(6237):423–424. doi: 10.1136/bmj.281.6237.423-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Weber M. A., Drayer J. I. Renal effects of beta-adrenoceptor blockade. Kidney Int. 1980 Nov;18(5):686–699. doi: 10.1038/ki.1980.186. [DOI] [PubMed] [Google Scholar]
  9. Wibell L. B. Studies on beta2-microglobulin in patients and normal subjects. Acta Clin Belg. 1976;31(8 Suppl):14–26. [PubMed] [Google Scholar]
  10. Wilkinson R. Beta-blockers and renal function. Drugs. 1982 Mar;23(3):195–206. doi: 10.2165/00003495-198223030-00002. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES